Scotland's Nebu~Flow bags 5.5M to develop next-gen inhalable drugs for respiratory disorders
Briefly

Glasgow-based Nebu~Flow secured approximately 5.50M in funding to progress the development of advanced inhaled drugs for respiratory disorders.
Scottish Enterprise Director highlights Nebu~Flow's journey from inception to funding and the importance of companies like Nebu~Flow in transforming the economy and delivering benefits to respiratory patients globally.
Read at siliconcanals.com
[
add
]
[
|
|
]